M. Karen Newell - Concepedia

Concepedia

Author

M. Karen Newell

University of Vermont

Also Known As

M K Newell, M Karen Newell, M. K Newell, M. K. NEWELL, M. K. Newell, M. KAREN NEWELL, M. Karen Newell, M.K. Newell, M.Karen Newell, Marie-Lousie Newell

40

Publications

3.4K

Citations

23

H-Index

67

Concepts

All Affiliations

University of Vermont University of Colorado Denver National Jewish Health University of Colorado Colorado Springs University of Colorado Health

MK

About

M. Karen Newell is an author at University of Vermont specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	2.3K
2	Allergy	5	5	285
3	Engineering	1	1	20
4	Natural Sciences	1	1	16
5	Public Health	1	1	20

M. Karen Newell

×

31

Publications

3.4K

Citations

23

H-Index

	Year	Citations
The CD95 Receptor: Apoptosis Revisited Marcus E. Peter, Ralph C. Budd, Julie Desbarats, Cell Cd95 ReceptorApoptosisImmunologyCell DeathImmunotherapy	2007	389
Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen M. Karen Newell, Lori Haughn, Christiane R. Maroun, Nature Autoimmune DiseaseSeparate LigationT-regulatory CellImmunologyMature T Cells	1990	371
Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes John C. Cambier, M. Karen Newell, Louis B. Justement, Nature Signal TransductionCell RegulationCell TraffickingImmunologyB Lymphocytes	1987	315
Fas engagement induces neurite growth through ERK activation and p35 upregulation Julie Desbarats, Raymond B. Birge, Manuelle Mimouni-Rongy, Nature Cell Biology P35 UpregulationReductive StressMolecular PhysiologyDevelopmental BiologySignal Transduction	2003	305
Fas engagement accelerates liver regeneration after partial hepatectomy Julie Desbarats, M. Karen Newell Nature Medicine Regenerative MedicineHepatologyLiver PhysiologyHepatology InflammationSurgery	2000	238
T Helper–Cell Phenotype Regulates Atherosclerosis in Mice Under Conditions of Mild Hypercholesterolemia Sally A. Huber, Pamela A. Sakkinen, Chella S. David, Circulation	2001	211
Characterization of a novel metabolic strategy used by drug‐resistant tumor cells Mary‐Ellen Harper, A. Antoniou, Elizabeth Villalobos‐Menuey, The FASEB Journal	2002	171
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyTwo-dose Heterologous Ad26.zebovVaccine Surveillance	2020	164
Vγ1+ T Cells Suppress and Vγ4+ T Cells Promote Susceptibility to Coxsackievirus B3-Induced Myocarditis in Mice Sally A. Huber, Danielle Graveline, M. Karen Newell, The Journal of Immunology	2000	136
Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. M. Karen Newell, J VanderWall, K. Scott Beard, Proceedings of the National Academy of Sciences HistocompatibilityClass IiApoptosisImmunologyHla Immunogenetics	1993	113

Page 1